Every 10-Q that Marsh (MRSH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MRSH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MRSH filings page.
Marsh & McLennan Companies, Inc. (MRSH) reported third-quarter 2026 revenue of $6.863 billion and net income attributable to the company of $808 million, compared with $6.351 billion and $747 million a year earlier. Diluted earnings per share were $1.69 versus $1.51. Risk and Insurance Services revenue was $4.200 billion and Consulting revenue was $2.685 billion, compared with $3.907 billion and $2.465 billion, respectively, in third-quarter 2025.
For the nine months ended September 30, 2026, revenue was $21.864 billion and net income attributable to the company was $3.220 billion, versus $20.386 billion and $3.339 billion, respectively. Net cash provided by operations was $2.313 billion, compared with $3.131 billion a year earlier. The company completed six Risk and Insurance Services acquisitions and two Consulting acquisitions, with total purchase consideration of $550 million.
Marsh & McLennan repurchased 11.4 million shares for $2.0 billion during the nine-month period and had authorization to repurchase up to approximately $3.7 billion as of September 30, 2026. A $0.990-per-share dividend declared in September is payable in November 2026. In the third quarter of 2026, the estimated cost of the three-year Thrive program was increased to approximately $750 million from $500 million; $310 million had been incurred through September 30, 2026.
Marsh & McLennan Companies reported Q2 2026 revenue of $7,404 million, up from $6,974 million a year earlier. Net income attributable to the company was $1,266 million and diluted EPS was $2.63, compared with $1,211 million and $2.45.
For the first half of 2026, revenue was $15,001 million versus $14,035 million, while net income attributable declined to $2,412 million from $2,592 million as expenses, including $103 million of restructuring costs under the three‑year Thrive program, weighed on results. Operating cash flow was $835 million, down from $1,049 million.
At June 30, 2026, total assets were $59,682 million, cash and cash equivalents were $1,700 million plus $12,203 million held in a fiduciary capacity, and long‑term debt was $18,891 million. The company repurchased 8.7 million shares for $1.5 billion and paid dividends of $1.80 per share in the first half.
Marsh & McLennan Companies reported lower profitability for the quarter ended March 31, 2026, despite higher revenue. Revenue rose to $7.60 billion from $7.06 billion, driven by both Risk & Insurance Services and Consulting.
Operating income declined to $1.75 billion from $2.01 billion, largely due to a $425 million legal liability and related costs recorded in Risk & Insurance Services for Greensill-related proceedings in Australia. Net income attributable to the company fell to $1.15 billion, with diluted EPS down to $2.36 from $2.79.
Operating cash flow was a $688 million outflow, reflecting seasonal working capital movements and compensation payments. The company continued returning capital, repurchasing 4.2 million shares for $750 million and declaring dividends of $1.80 per share for the period, while restructuring under its three‑year “Thrive” program added $45 million of charges.